Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

ORIG3N
27 Drydock Ave.
Boston, MA 02210
Phone: 617-943-7800
http://www.orig3n.com/

ORIG3N is a biotechnology company developing a breakthrough disease-modeling platform targeting rare genetically inherited diseases. By advancing screening projects using iPSC-derived differentiated cells and rapidly delivering the resulting data to inform therapeutic decisions, ORIG3N will replace trial and error guess work of treating disease and enable longer, healthier lives. The founders are serial entrepreneurs who's previous venture, ArtusLabs, was acquired by PerkinElmer in 2011.

Key Contact
Name
Robin Y. Smith
Title
CEO
Funding Events

Date
Amount
Type
Investors
Valuation
02/17/15 $3,100,000 Harris & Harris Group
Hatteras Venture Partners
KTB Ventures
Mountain Group Capital
undisclosed
12/17/15 $12,500,000 Series A DEFTA Partners
Harris & Harris Group
Hatteras Venture Partners
KTB Ventures
Laboratory Corporation of America
MGC Venture Partners
Syno Capital
undisclosed
06/27/17 $20,000,000 180 Degree Capital
DEFTA Partners
Hatteras Venture Partners
KTB-KORUS Fund
LabCorp
MGC Venture Partners
Spectrum Health Ventures
Syno Capital
undisclosed
07/12/18 undisclosed Series B 180 Degree Capital
Alexandria Venture Investments
DEFTA Partners
Haitong International Securities
Hatteras Venture Partners
KTB Ventures
LabCorp
MMIC Investment Holdings
Mountain Group Capital
Spectrum Health Ventures
Vectr Ventures
undisclosed


Featured Reading